Dec 23, 2006
FDA Approves Cool-Cap
Via BrainBlog
FDA Approves Novel Device That Prevents or Reduces Brain Damage in Infants (FDA press release)
The Food and Drug Administration (FDA) today approved a first-of-a-kind medical device for the treatment of babies born with moderate to severe hypoxic-ischemic encephalopathy (HIE), a potentially fatal injury to the brain caused by low levels of oxygen. The Olympic Cool-Cap system is designed to prevent or reduce damage to the brains of these patients by keeping the head cool while the body is maintained at a slightly below-normal temperature. The Cool-Cap is manufactured by Olympic Medical Corporation, a subsidiary of Natus Medical Incorporated of San Carlos, Calif.
Read the full PR
14:03 Posted in Neurotechnology & neuroinformatics | Permalink | Comments (0) | Tags: neurotechnology
The comments are closed.